Tevogen Bio Holdings (TVGN) Non Operating Income (2022 - 2023)
Tevogen Bio Holdings (TVGN) reported Non Operating Income of -$181416.0 for Q4 2023, down 106.42% on a YoY basis from $2.8 million in Q4 2022, and down 155.44% quarter-over-quarter from $327225.0 in Q3 2023.
Tevogen Bio Holdings (TVGN) Non Operating Income (2022 - 2023) Analysis & Trends
Tevogen Bio Holdings has reported Non Operating Income for 2 years, with the latest figure at -$181416.0 in Q4 2023.
- For the quarter ending Q4 2023, Non Operating Income fell 106.42% year-over-year to -$181416.0; the trailing twelve-month figure through Dec 2023 stood at $2.2 million (down 58.84% YoY), and the FY2023 full-year result was $2.2 million, down 58.84% from the prior year.
- Non Operating Income for Q4 2023 stood at -$181416.0, down from $327225.0 in the prior quarter.
- The five-year high for Non Operating Income was $2.8 million in Q4 2022, with the low at -$181416.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Tevogen Bio Holdings | 173.69 Mn | 173.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -181,416.00 |
| Sep 30, 2023 | 327,225.00 |
| Jun 30, 2023 | 331,524.00 |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 2.83 Mn |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 465,583.00 |
| Mar 31, 2022 | 256,891.00 |